Real4Reg – Unlocking Real-World Data with AI
Real4Reg is a consortium of ten European institutions which aims to promote the use of real-world data (national healthcare registers and claims data) to support the regulatory decisions about medicines. Real4Reg will take advantage of ground-breaking technologies such as artificial intelligence and machine learning.
The structure and approach of our project aim to facilitate the implementation of the effective use of real-world data in regulatory decision-making and health technology assessment.
Data & Methods
Real4Reg will use data sources from four European countries (Denmark, Finland, Germany, and Portugal) and will develop solutions to address the data analytical needs of regulatory agencies.
From a methodological point of view, the project is aligned with the decision-making process in regulatory agencies, which can be broadly broken down into the pre-authorisation, evaluation, and post-authorisation phases of the product lifecycle.
Use Cases
-
Latest News
Presentation of Real4Reg survey results in Dresden, Germany
Read more: Presentation of Real4Reg survey results in Dresden, GermanyIn early September, Dresden was the venue of a joint conference of five German medical associations, enabling cross-sectional knowledge sharing across a range of scientific expertise. Almost 2000 scientists attended the conference and discussed topics such as discussed topics related to epidemiology, health technology assessment and public health such as gender, planetary/environmental health, artificial intelligence,…
-
Latest News
Real4Reg workshops 2024
Read more: Real4Reg workshops 2024The Real4Reg project is dedicated to fostering active engagement with key stakeholders, including experts in real-world data and medicines, as well as the public and patients. We are excited to announce two workshops scheduled for October 14. The final programs and speakers will be announced in the coming weeks.
Who we are
Our consortium assembles ten partners from six different European countries with experience in the field of RWD analyses, including experts from regulatory agencies and health technology assessment bodies, academia, and patient organisations.
A project for the Patients
Real4Reg integrates two patient organisations to incorporate the patients’ perspectives and expectations along its work.